amyotrophic lateral sclerosis
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Patients who were diagnosed as "possible ALS", "probable ALs laboratory-supported", "probable ALS", or "definite ALS" in the El Escorial diagnostic criteria revised. Otherwise, patients who were diagnosed as "possible ALS", "probable ALs laboratory-supported", "probable ALS", or "definite ALS" in the updated Awaji criteria. Both sporadic and familial ALS patients will be assigned.
Exclusion criteria
Exclusion criteria: 1. Patients who have participated in a clinical trial for ALS and have been administered the investigational drug 2. Patients who have other serious complications and are considered unsuitable for the natural history survey by the investigator
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| 1. ALSFRS-R change rate 2. Period from onset to death or tracheostomy/invasive positive pressure ventilation 3. Period from onset to full-day non-invasive positive pressure ventilation (>22 hours/day) | — |
Countries
Japan
Contacts
Tohoku University Hospital Department of Neurology